ORYZON to Provide Corporate Progress Updates at Several Events in March-April
Van Lanschot Kempen Life Sciences Conference MADRID, Spain and CAMBRIDGE, Mass., March 14, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage ...
腾讯网14 天
复旦大学附属华东医院血液科在权威期刊发文 发现治疗TP53突变 ...
复旦大学附属华东医院血液科近日在血液领域权威期刊Blood Cancer Journal上在线发表了题为“Decitabine with etoposide is effective in TP53 mutated myeloid tumors via overcoming differentiation block”的论文。该研究发现两种药物依托泊苷联合地西他滨治疗极其难治的TP53突变急性髓细 ...
Medical News Today21 天
What medications cause hair loss?
Doctors refer to hair loss that occurs as a side effect of medication as drug-induced alopecia. Hair loss can be a side effect of many different medications, such as those for chemotherapy ...
National Institute for Health and Care Excellence29 天
Durvalumab with etoposide and either carboplatin or cisplatin for untreated extensive-stage ...
There is a commercial access agreement for durvalumab. NHS organisations can get details on the Commercial Access and Pricing (CAP) Portal. Non-NHS organisations can contact ...
ascopubs.org1 个月
Clinical experience with EMACO chemotherapy in male choriocarcinoma: A single-center study.
Post chemotherapy retroperitoneal lymph node dissection (PC-RPLND) for metastatic pure seminoma. Functional and oncological outcome of primary nerve sparing retroperitoneal lymph node dissection in ...